英格兰启动AI试验 用于同一天的前列腺癌诊断 以减少等待和焦虑 England launches AI trial for same-day prostate cancer diagnosis to cut waits and anxiety.

国民保健体系正在利用人工智能进行一项试验,以便能够对英格兰男子进行同一天的前列腺癌诊断,目的是缩短长时间的等待时间,减少病人的焦虑。 The NHS is launching a trial using artificial intelligence to enable same-day prostate cancer diagnosis for men in England, aiming to cut long wait times and reduce patient anxiety. AI工具Lucida Medical的Pi分析磁共振扫描以快速识别高风险损害, The AI tool, Pi by Lucida Medical, analyzes MRI scans to quickly identify high-risk lesions, allowing for immediate specialist review and same-day biopsy appointments. 由于2024年英格兰有58 000多名男子被诊断患有前列腺癌,这项在多达15家医院进行的试验有助于更快地进行诊断和治疗,特别是至关重要的诊断和治疗。 The trial, running at up to 15 hospitals, supports faster diagnosis and treatment, especially critical given that over 58,000 men were diagnosed with prostate cancer in England in 2024. 卫生官员和倡导者将该倡议称为潜在的游戏变革者,强调改善的结果、减轻压力和对保健工作人员的救济。 Health officials and advocates call the initiative a potential game changer, highlighting improved outcomes, reduced stress, and relief for healthcare staff. 这项努力与即将出台的《国家癌症计划》保持一致,是通过数字创新实现癌症护理现代化的一个重大步骤。 The effort aligns with the upcoming National Cancer Plan and represents a major step in modernizing cancer care through digital innovation.